DZIF - Deutsches Zentrum für Infektionsforschung

dzif.bsky.social

14 October 2026 12:11

🦠 Can an Ebola vaccine trigger T-cell responses against a related virus? A DZIF-led study in The Lancet Infectious Diseases finds that a single dose of the licensed Ebola vaccine can induce T cells that recognize Bundibugyo virus (BDBV). 👉 Read more: t1p.de/s75j4

DZIF - Deutsches Zentrum für Infektionsforschung

dzif.bsky.social

28 September 2026 08:03

A new way to target drug-resistant #tuberculosis: An international team including #DZIF scientists has shown how the natural compound #corramycin targets DNA gyrase and why it remains effective against fluoroquinolone-resistant bacteria. 👉 Read more: t1p.de/t7m2a #TB #DrugDevelopment

LMU München

lmu.de

21 August 2026 08:03

🌍 Where does global health funding go – and where is it needed most? #LMU researchers analyzed 3.7 million aid projects using #MachineLearning and uncovered major imbalances in disease-specific funding. These findings provide an important basis for political decision-making. #LMUMunich #GlobalHealth

MONID - Modeling Network for Severe Infectious Diseases

monid-mod.bsky.social

18 August 2026 11:00

#MONID #HABITRACK

tbnet.bsky.social

18 August 2026 10:59

Together against antibiotic-resistant tuberculosis in Europe On 8–9 June 2026, more than 50 leading specialists in the field gathered in Chisinau, Republic of Moldova, for the 1st Antimicrobial Stewardship in Tuberculosis Conference Read more about the conference here: www.tbnet.eu/post/togethe...